First-In Man (FIM) Study MR-Linac

NCT03284619 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
5
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Nucletron Operations BV

Collaborators